Results 31 to 40 of about 706,445 (241)

Investigating the role of minichromosome maintenance protein 2 in differentiating follicular adenoma from follicular carcinoma of thyroid

open access: yesAmerican Journal of Experimental and Clinical Research, 2021
Thyroid nodules are often discovered incidentally in the clinical practice. Even though definite preoperative diagnosis of follicular thyroid lesions prevents unnecessary thyroid surgeries, fine needle aspiration (FNA) cannot definitely differentiate ...
Mahmood Akhavan Tafti   +6 more
doaj  

Application of Galectin-3, HBME-1, Cytokeratin-19, and CD56 in the Diagnosis of Thyroid Neoplasm

open access: yesCentral Asian Journal of Medical Sciences, 2019
Objective: The purpose of this study was to investigate the effectiveness of immunohistochemical thyroid malignancy markers Galectin-3, HBME-1, Cytokeratin-19, and CD56 in the diagnosis of thyroid neoplasm. Methods: The study included a total of 53 cases
Suren Okdoo   +7 more
doaj   +1 more source

A rare case of follicular thyroid carcinoma with metastasis to the scalp

open access: yesSouth African Medical Journal, 2022
Follicular thyroid carcinoma accounts for 10% of thyroid carcinomas. Cutaneous metastases are rare and usually indicate an advanced tumour stage. We present a case of follicular thyroid carcinoma with scalp metastases.
T Gvilia, M Tun
doaj   +1 more source

Histopathological and immunohistochemical features of thyroid carcinoma [PDF]

open access: yesArchive of Oncology, 2003
Thyroid-specific malignant tumors are derived from follicle cells (papillary and follicular carcinoma), and from parafollicular, calcitonin-producing C-cells (medullary carcinoma). The main criterion for diagnosis of papillary carcinoma is the occurrence
Tatić Svetislav B.
doaj   +1 more source

Determination of galectin-3 expression in the tissue of follicular thyroid tumors

open access: yesКлиническая и экспериментальная тиреоидология, 2011
The aim of this study was to investigate the usefulness of immunohistochemical expression galectin-3 for differential diagnosis follicular carcinoma and follicular adenoma in a sample of thyroid lesions using a specific antigalectin-3 monoclonal antibody.

doaj   +1 more source

Biological function of Cl 2 gene and it’s role in thyroid cancer [PDF]

open access: yes, 2011
Here I report data to support a tumor suppressor role of the Cl 2 gene. Indeed, I detected a drastic reduction, of Cl 2 gene expression in almost all thyroid carcinomas analyzed, with respect to normal thyroid, with the lowest expression levels observed ...
Ferraro, Angelo
core   +1 more source

Correlation between BRAF mutation and the clinicopathological parameters in papillary thyroid carcinoma with particular reference to follicular variant [PDF]

open access: yes, 2011
Mutation of the BRAF gene is common in thyroid cancer. Follicular variant of papillary thyroid carcinoma is a variant of papillary thyroid carcinoma that has created continuous diagnostic controversies among pathologists. The aims of this study are to (1)
Ariana, Armin   +14 more
core   +2 more sources

Thyroid Papillary Carcinoma Follicular Variant: Which Surgical Approach?

open access: yes, 2014
In general, fine needle aspiration biopsy (FNAB) is insufficient and inadequate in the diagnosis of follicular variant of thyroid papillary carcinoma. Especially in capsulated forms of the carcinoma, diagnostic difficulties are pronounced because of the ...
M. Gazi Yıldız   +9 more
core   +1 more source

The diagnostic significance of trophoblast cell-surface antigen-2 expression in benign and malignant thyroid lesions

open access: yesIndian Journal of Pathology and Microbiology, 2019
Context: Thyroid cancers are the most common malignancy of the endocrine system. Over-expression of trophoblast cell-surface antigen 2 (TROP-2) in various tumors has been found to correlate with poor prognosis and aggressive tumor behavior. Aims: The aim
Canan Sadullahoğlu   +6 more
doaj   +1 more source

Epigenetic reprogramming of lineage switching in cancer

open access: yesFEBS Letters, EarlyView.
Cancer cells rarely commit to a single identity. Epigenetic mechanisms and tumor microenvironment cues push epithelial cells toward flexible, hybrid states that can shift into mesenchymal, neuroendocrine, or stem‐like fates, driving metastasis, drug resistance, and tumor heterogeneity. Targeting the epigenetic regulators behind these transitions, using
Ezgi Boyvatlı   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy